Compare products Close window [X]

Prasugrel Nitroso Impurity 1 is chemically 5-Nitroso-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one.
Prasugrel Nitroso Impurity 1 is supplied with detailed characterization data compliant with regulatory guideline. Prasugrel Nitroso Impurity 1 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Prasugrel.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. ISP Standards products are for analytical purpose only and not for human use.

Tacrolimus Ring-Opening Impurity is chemically (3S,4R,5S,8R,12S,14S,15R,16S,18R,26aS,Z)-8-Allyl-5,15-dihydroxy-3-((E)-1-((1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl)prop-1-en-2-yl)-14,16-dimethoxy-4,10,12,18-tetramethyl-5,6,11,12,13,14,15,16,17,18,24,25,26,26a-tetradecahydro-3H-pyrido[2,1-c][1]oxa[4]azacyclotricosine-1,7,19,20,21(4H,8H,23H)-pentaone. Tacrolimus Ring-Opening Impurity is supplied with detailed characterization data compliant with regulatory guideline. Tacrolimus Ring-Opening Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tacrolimus.The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. ISP Standards products are for analytical purpose only and not for human use.

Ziprasidone EP Impurity D is chemically 5,5′-bis[2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-yl]ethyl]-6,6′-dichloro-3-hydroxy-1,1′,3,3′-tetrahydro-2H,2’H-3,3′-biindole-2,2′-dione,.
It is also known as Ziprasidone USP Related Compound C.
Ziprasidone EP Impurity D is supplied with detailed characterization data compliant with regulatory guideline. Ziprasidone EP Impurity D can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ziprasidone .

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. ISP Standards products are for analytical purpose only and not for human use.